Fricke-Galindo, I.; Buendia-Roldan, I.; Ponce-Aguilar, D.I.; Pérez-Rubio, G.; Chavez-Galan, L.; Alanis-Ponce, J.; Pérez-Torres, K.; Valencia-Pérez Rea, D.; Téllez-Quijada, F.; Nava-Quiroz, K.J.;
et al. The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients. Int. J. Mol. Sci. 2023, 24, 7678.
https://doi.org/10.3390/ijms24087678
AMA Style
Fricke-Galindo I, Buendia-Roldan I, Ponce-Aguilar DI, Pérez-Rubio G, Chavez-Galan L, Alanis-Ponce J, Pérez-Torres K, Valencia-Pérez Rea D, Téllez-Quijada F, Nava-Quiroz KJ,
et al. The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients. International Journal of Molecular Sciences. 2023; 24(8):7678.
https://doi.org/10.3390/ijms24087678
Chicago/Turabian Style
Fricke-Galindo, Ingrid, Ivette Buendia-Roldan, Daniel I. Ponce-Aguilar, Gloria Pérez-Rubio, Leslie Chavez-Galan, Jesús Alanis-Ponce, Karina Pérez-Torres, Daniela Valencia-Pérez Rea, Fernanda Téllez-Quijada, Karol J. Nava-Quiroz,
and et al. 2023. "The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients" International Journal of Molecular Sciences 24, no. 8: 7678.
https://doi.org/10.3390/ijms24087678
APA Style
Fricke-Galindo, I., Buendia-Roldan, I., Ponce-Aguilar, D. I., Pérez-Rubio, G., Chavez-Galan, L., Alanis-Ponce, J., Pérez-Torres, K., Valencia-Pérez Rea, D., Téllez-Quijada, F., Nava-Quiroz, K. J., Hernández-Zenteno, R. d. J., Gutiérrez-Nava, A., & Falfán-Valencia, R.
(2023). The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients. International Journal of Molecular Sciences, 24(8), 7678.
https://doi.org/10.3390/ijms24087678
